原生T1 mapping作为识别高级别肾细胞癌的体内生物标志物:与组织病理学表现的关联
这项单中心前瞻性研究纳入30例透明细胞肾细胞癌(cRCC)患者和30名健康对照,采用1.5 T磁共振原生T1 mapping(MOLLI序列)定量测量T1值,并与组织病理胶原容积分数对照。结果显示低级别cRCC(ISUP 1–2级)原生T1值显著低于高级别cRCC(ISUP 3–4级;P<0.001),以1101毫秒为界值区分高低级别的敏感度100%、特异度85%、准确率90%,且T1值与胶原容积分数显著相关(P<0.05)。
要点
- 低级别cRCC原生T1值显著低于高级别cRCC(P<0.001)。
- 以1101毫秒为界值区分高低级别cRCC,敏感度100%、特异度85%、准确率90%。
- 原生T1值与组织病理胶原容积分数显著相关(P<0.05)。
核心结论
- 原生T1 mapping可能作为区分低级别与高级别cRCC的体内生物标志物,在定性磁共振特征之外提供增量诊断价值。
研究设计与样本
- 经机构审查委员会批准的单中心前瞻性研究,2017年1月至2018年7月连续纳入68例患者行1.5 T腹部磁共振扫描(MOLLI序列),最终30例cRCC患者(20例男性;平均年龄61.9±13.1岁)接受部分或根治性肾切除术并按ISUP分类行组织学分级,另设30名无肾脏恶性肿瘤或复杂囊肿的健康对照(16例男性;平均年龄59.7±14.6岁)。
诊断标准与关键数值
- 低级别cRCC(ISUP 1和2级)原生T1值显著低于高级别cRCC(ISUP 3和4级;P<0.001);以1101毫秒为界值区分高级别与低级别肿瘤,敏感度100%(95%CI 0.69–1.00)、特异度85%(95%CI 0.62–0.97)、准确率90%(95%CI 0.73–0.98);原生T1值与组织学胶原容积分数显著相关(P<0.05)。
临床应用与阅片要点
- 在T1图上通过感兴趣区定量测量肿瘤原生T1值,可用于辅助区分低级别与高级别cRCC;肾皮质、肾髓质和肿瘤组织的T1时间显示极好的观察者间一致性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aims of this study were to identify higher-grade clear cell renal cell carcinoma (cRCC) with native T1 mapping and to histologically correlate the results with the collagen volume fraction.
MATERIALS AND METHODS: For this institutional review board-approved, single-center prospective study, 68 consecutive patients received abdominal magnetic resonance imaging scans at 1.5 T between January 2017 and July 2018, using a Modified Look-Locker Inversion Recovery (MOLLI) sequence. Thirty patients with cRCC (20 men; mean age, 61.9 ± 13.1 years) who underwent partial or radical nephrectomy and histological grading according to the International Society of Urological Pathology (ISUP) classification and a separate healthy cohort of 30 individuals without renal malignancies or complex cysts (16 men; mean age, 59.7 ± 14.6 years) met the eligibility criteria. T1 values were quantitatively measured with region of interest measurements in T1 maps. Quantification of the collagen volume fraction was performed on histological sections (picrosirius red staining).
RESULTS: Native T1 values were significantly lower for lower-grade cRCC (ISUP 1 and 2) compared with higher-grade cRCC (ISUP 3 and 4; P < 0.001). A cutoff value of 1101 milliseconds distinguished higher-grade from lower-grade tumors with a sensitivity of 100% (95% confidence interval [CI], 0.69-1.00), a specificity of 85% (95% CI, 0.62-0.97), and an accuracy of 90% (95% CI, 0.73-0.98). Native T1 values were significantly associated with the histological collagen volume fraction (P < 0.05). Furthermore, T1 times in the renal cortex, medulla, and tumor tissue showed an excellent interobserver agreement.
CONCLUSIONS: Native T1 mapping could represent an in vivo biomarker for the differentiation of lower- and higher-grade cRCCs, providing incremental diagnostic value beyond qualitative magnetic resonance imaging features.
引用
- Adams LC, Ralla B, Jurmeister P, et al. Native T1 Mapping as an In Vivo Biomarker for the Identification of Higher-Grade Renal Cell Carcinoma: Correlation With Histopathological Findings. Invest Radiol. 2019. PMID: 30379727. doi:10.1097/RLI.0000000000000515
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。